Achiko Initiates Development of Dengue Diagnostic Test
November 05, 2021 07:30 ET
|
Achiko AG
Achiko to develop dengue fever diagnostic test by applying its DNA aptamer technology platform. This is another promising application of the technology that Achiko is already successfully using to...
Achiko Secures Initial Sales of AptameX Covid-19 Diagnostic Test
October 27, 2021 07:30 ET
|
Achiko AG
Achiko has received its first purchase order in Jakarta and Bali in Indonesia.The orders translate to 20,000 tests - while modest in size, the order is expected to pave the way to rapid adoption by...
Market Outlook and Production Plan Update for AptameX
October 20, 2021 07:30 ET
|
Achiko AG
After receiving product and registration approval from Indonesia’s Ministry of Health in August, Achiko is positioned to produce up to a million AptameX test kits in Q4 2021, and more if the supply...
Achiko Launches Covid-19 Testing Pilot Program in Indonesia
October 07, 2021 07:30 ET
|
Achiko AG
Launch of pilot program in Indonesia for Achiko’s proprietary, low-cost rapid Covid-19 diagnostic test, AptameX, alongside its sister digital passporting service, Teman Sehat (“Health Buddy”).Purpose...
Achiko’s Rapid Covid-19 Diagnostic Test AptameX™ Receives Product and Registration Approval from Indonesia’s Ministry of Health
August 25, 2021 07:30 ET
|
Achiko AG
AptameX™, Achiko’s breakthrough DNA aptamer-based diagnostic test for Covid-19, received product and registration emergency use approval from the Ministry of Health in Indonesia, alongside its sister...
Achiko Engages EpiMetrics to Expand Covid-19 Testing Operations with Udayana University in Bali, Indonesia in the Implementation of a Mass Testing Program
July 15, 2021 07:30 ET
|
Achiko AG
ZURICH, Switzerland, July 15, 2021 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Achiko AG (SWX:ACHI, ISIN CH0522213468) (“Achiko”, the “Company”), a global healthtech company...
Achiko Working Towards a Solution for Frequent Global Mass COVID-19 Testing
July 13, 2021 07:30 ET
|
Achiko AG
ZURICH, Switzerland, July 13, 2021 (GLOBE NEWSWIRE) -- Achiko AG (SWX:ACHI, ISIN CH0522213468) (“Achiko”, the “Company”), a global healthtech company currently developing technologies that seek to...
Achiko Announces an Extension of its Convertible Loan Transaction with Negma Group
June 18, 2021 12:01 ET
|
Achiko AG
ZURICH, June 18, 2021 (GLOBE NEWSWIRE) -- Achiko AG (SWX:ACHI, ISIN CH0522213468) (“Achiko”, the “Company”) has successfully extended the subordinated convertible loan agreement of CHF 900,000 dated...
Achiko Announces the Successful Integration of its Teman Sehat Digital Ecosystem and AptameX Covid-19 Diagnostic Testing Platform for Launch in Indonesia
June 03, 2021 07:30 ET
|
Achiko AG
Wireless integration of AptameX Covid-19 test with Teman Sehat completedTeman Sehat’s open API allows for integration of third party testing platformsTeman Sehat provides results within 15 minutes,...
Achiko AG Announces Successful Integration of its Teman Sehat Digital Ecosystem and AptameX Covid-19 Diagnostic Testing Platform for Launch in Indonesia
June 03, 2021 00:45 ET
|
Achiko AG
Wireless Integration of AptameX Covid-19 Test with Teman Sehat CompletedTeman Sehat’s Open API Allows for Integration of Third Party Testing PlatformsTeman Sehat Provides Results within 15 minutes,...